Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KOSDAQ/047920 stock hub

KOSDAQ/047920 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/047920is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

230.3B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/047920

In the news

Latest news · KOSDAQ/047920

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E117.1

P25 12P50 23.1P75 39.5

ROE3.8

P25 -17.1P50 0.7P75 8.5

ROIC0.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/047920 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

KRW

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 228.8B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7047920004
Last refreshed	2026-05-10
Market cap	KRW 230.3B
Price	KRW 16,400
Price currency	KRW
Sector	Healthcare
Sic	2834
Symbol	kosdaq/047920
Website	https://www.hlbpharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.99%
EV Earnings	50.06x
EV/EBIT	67.54x
EV/EBITDA	30.51x
EV/FCF	-34.46x
EV/Sales	1.11x
FCF yield	-2.88%
P/B ratio	1.84x
P/E ratio	117.14x
P/S ratio	1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.52%
EBITDA Margin	2.52%
Gross margin	51.76%
Gross Profit	KRW 106.4B
Gross Profit Growth	489.83%
Gross Profit Growth Q	53.94%
Net Income	KRW 4.6B
Net Income Growth	867.25%
Net Income Growth Q	3.2%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	2.43%
Profit Margin	2.22%
Profitable Years	2
ROA	0.4
ROCE	0.81
ROE	3.79
ROIC	0.83
Roic5y	-7.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.81%
Cagr1y	-21.17%
Cagr3y	2.52%
Cagr5y	1.2%
EPS Growth	310.2
EPS Growth Q	-7.24
EPS Growth Years	2
OCF Growth	-57.96%
OCF Growth Q	94.14%
Revenue Growth	469.48x
Revenue Growth Q	91.67x
Revenue Growth Quarters	4x
Revenue Growth Years	8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.25
Assets	KRW 170.7B
Cash	KRW 22.1B
Current Assets	KRW 76.7B
Current Liabilities	KRW 39.6B
Debt	KRW 20.7B
Debt EBITDA	KRW 4
Debt Equity	KRW 0.17
Debt FCF	KRW -3.11
Equity	KRW 125.1B
Interest Coverage	1.44
Liabilities	KRW 45.5B
Long Term Assets	KRW 94B
Long Term Liabilities	KRW 5.9B
Net Cash	KRW 1.5B
Net Cash By Market Cap	KRW 0.63
Net Cash Growth	-75.53%
Net Debt EBITDA	KRW -0.28
Net Debt Equity	KRW -0.01
Tangible Book Value	KRW 121.4B
Tangible Book Value Per Share	KRW 3,714
WACC	6.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.94
Inventory Turnover	3.79
Net Working Capital	KRW 31.5B
Quick ratio	1.17
Working Capital	KRW 37.1B
Working Capital Turnover	KRW 6.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-135.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	60%
1Y total return	-21.15%
200-day SMA	15,892.4
3Y total return	7.75%
50-day SMA	16,460.6
50-day SMA vs 200-day SMA	50over200
5Y total return	6.15%
All Time High	42,050
All Time High Change	-61%
All Time High Date	2024-03-21
All Time Low	2,665
All Time Low Change	515.38%
All Time Low Date	2020-03-23
ATR	698.4
Beta	0.4
Beta1y	0.41
Beta2y	0.12
Ch YTD	2.24
High	16,870
High52	22,250
High52 Date	2026-01-26
High52ch	-26.29%
Low	16,350
Low52	12,500
Low52 Date	2025-10-13
Low52ch	31.2%
Ma50ch	-0.37%
Price vs 200-day SMA	3.19%
RSI	40.72
RSI Monthly	47.28
RSI Weekly	49.64
Sharpe ratio	-0.23x
Sortino ratio	-0.22
Total Return	-135.81%
Tr YTD	2.24
Tr1m	-0.24%
Tr1w	-5.04%
Tr3m	5.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 1.1B
Operating Income Growth	-26.17
Operating margin	0.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,175,800%
Net Borrowing	-1,168,417,190
Shares Insiders	11.17%
Shares Institutions	0.53%
Shares Out	14,042,291
Shares Qo Q	0.25%
Shares Yo Y	135.81%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -6.8B
Average Volume	136,417x
Bv Per Share	3,829.9
CAPEX	KRW -7.2B
Ch10y	60
Ch1m	-0.24
Ch1w	-5.04
Ch1y	-21.15
Ch3m	5.26
Ch3y	7.75
Ch5y	6.15
Ch6m	-1.44
Change	-2.09%
Change From Open	-2.15
Close	16,750
Days Gap	0.06
Depreciation Amortization	4,111,793,000
Dollar Volume	1,574,432,800
Earnings Date	2026-05-15
EBIT	KRW 1.1B
EBITDA	KRW 5.2B
EPS	KRW 140
F Score	6
FCF	KRW -6.6B
FCF EV Yield	-2.9x
FCF Per Share	KRW -473
Financing CF	17,866,943,120
Fiscal Year End	December
Founded	1,998
Goodwill	105,074,000
Graham Number	3473.37368
Graham Upside	-78.82
Income Tax	KRW 414M
Investing CF	-21,319,315,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2016-04-12
Last Split Type	Forward
Ma150	16,092.6
Ma150ch	1.91%
Ma20	17,676.5
Ma20ch	-7.22%
Net CF	-2,883,393,540
Next Earnings Date	2026-05-15
Open	16,760
P OCF Ratio	404.7
Position In Range	9.62
Ppne	44,387,927,790
Price Date	2026-05-08
Price EBITDA	KRW 44.5
Ptbv Ratio	1.9
Relative Volume	0.68x
Revenue	205,581,738,640x
SBC By Revenue	0.08x
Share Based Comp	173,441,000
Tax By Revenue	0.2x
Tax Rate	8.3%
Tr6m	-1.44%
Volume	96,002
Z Score	5.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/047920 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/047920 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/047920?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+135.8%

Negative means the company is buying back shares.

Technical

KOSDAQ/047920 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

+3.2%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/047920

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/047920 stock rating?

kosdaq/047920 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/047920 analysis?

The full report lives at /stocks/kosdaq/047920/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/047920?

The latest report frames kosdaq/047920 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/047920 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.